规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
---|---|---|---|---|---|---|---|---|---|
50mg | ¥ řȡƜȡȡ | > 0 | -- | -- | -- | -- | ¥ řȡƜȡȡ | - + | |
g | ¥ řƧƜȡȡ | > 0 | -- | -- | -- | ¥ řƧƜȡȡ | - + | ||
5g | ¥ œƧƜȡȡ | > 0 | -- | 3 | 6 | 7 | 3 | ¥ œƧƜȡȡ | - + |
0g | ¥ ŤȂŁƜȡȡ | > 0 | -- | 3 | 3 | ¥ ŤȂŁƜȡȡ | - + | ||
5g | ¥ ǝřȂƜȡȡ | > 0 | -- | ¥ ǝřȂƜȡȡ | - + | ||||
00g | ¥ ŤȂȡȡƜȡȡ | 8 | -- | ¥ ŤȂȡȡƜȡȡ | - + | ||||
500g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
000g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
大货 | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
9.5
[]. Kotla V, et al. Mechanism of action of lenalidomide in hematological malignancies. J Hematol Oncol. 009 Aug ;:36.
[]. Krönke J, et al. Lenalidomide induces degradation of IKZF and IKZF3. Oncoimmunology. 0 Jul 3;3(7):e97.
[3]. Lopez-Girona A, et al. Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. Leukemia. 0 Nov;6():36-35.
[]. Minzel W, et al. Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models. Cell. 08 Sep 0;75():7-85.e5.
[5]. Nagashima, Takeyuki, et al. PHARMACEUTICAL COMPOSITION COMPRISING BICYCLIC NITROGEN-CONTAINING AROMATIC HETEROCYCLIC AMIDE COMPOUND AS ACTIVE INGREDIENT. Patent. 070360780A.
H36-H373
P60-P80-P05-P50